Ferris Capital LLC boosted its stake in UnitedHealth Group Inc (NYSE:UNH) by 17.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,439 shares of the healthcare conglomerate’s stock after buying an additional 366 shares during the quarter. Ferris Capital LLC’s holdings in UnitedHealth Group were worth $717,000 at the end of the most recent reporting period.
Other institutional investors also recently modified their holdings of the company. Selective Wealth Management Inc. purchased a new position in UnitedHealth Group in the 3rd quarter valued at about $27,000. North Star Investment Management Corp. purchased a new position in UnitedHealth Group in the 3rd quarter valued at about $30,000. Delta Asset Management LLC TN lifted its stake in UnitedHealth Group by 111.0% in the 3rd quarter. Delta Asset Management LLC TN now owns 154 shares of the healthcare conglomerate’s stock valued at $33,000 after buying an additional 81 shares in the last quarter. Fusion Family Wealth LLC lifted its stake in UnitedHealth Group by 329.7% in the 3rd quarter. Fusion Family Wealth LLC now owns 159 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 122 shares in the last quarter. Finally, Massey Quick Simon & CO. LLC lifted its stake in UnitedHealth Group by 212.5% in the 3rd quarter. Massey Quick Simon & CO. LLC now owns 175 shares of the healthcare conglomerate’s stock valued at $38,000 after buying an additional 119 shares in the last quarter. 85.79% of the stock is currently owned by hedge funds and other institutional investors.
A number of research analysts recently weighed in on the stock. Jefferies Financial Group lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and decreased their price target for the company from $300.00 to $235.00 in a research note on Thursday, October 10th. BMO Capital Markets reaffirmed a “market perform” rating and issued a $310.00 price target on shares of UnitedHealth Group in a research note on Wednesday, December 4th. Cantor Fitzgerald raised their target price on shares of UnitedHealth Group from $315.00 to $330.00 and gave the stock an “overweight” rating in a research note on Thursday, January 16th. ValuEngine raised shares of UnitedHealth Group from a “sell” rating to a “hold” rating in a research note on Wednesday, October 2nd. Finally, Mizuho reissued a “buy” rating and issued a $300.00 target price (up from $270.00) on shares of UnitedHealth Group in a research note on Tuesday, November 26th. Five research analysts have rated the stock with a hold rating and nineteen have assigned a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $313.50.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Wednesday, January 15th. The healthcare conglomerate reported $3.90 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $3.77 by $0.13. The firm had revenue of $60.90 billion for the quarter, compared to analyst estimates of $61.17 billion. UnitedHealth Group had a net margin of 5.71% and a return on equity of 25.55%. The business’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $3.28 EPS. On average, equities analysts anticipate that UnitedHealth Group Inc will post 16.47 earnings per share for the current fiscal year.
In other news, EVP D Ellen Wilson sold 7,400 shares of UnitedHealth Group stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $272.77, for a total transaction of $2,018,498.00. Also, CAO Thomas E. Roos sold 1,177 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, November 7th. The shares were sold at an average price of $255.04, for a total transaction of $300,182.08. Following the sale, the chief accounting officer now directly owns 21,687 shares in the company, valued at approximately $5,531,052.48. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 23,577 shares of company stock worth $6,810,430. Corporate insiders own 0.87% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Article: Commodities
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.